Apollon Wealth Management, LLC Harrow Health, Inc. Transaction History
Apollon Wealth Management, LLC
- $5.29 Billion
- Q3 2025
A detailed history of Apollon Wealth Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 4,684 shares of HROW stock, worth $194,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,684Holding current value
$194,386% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
185Shares Held
21.6MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$162 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$89.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$80.7 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$77.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$36.2 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.12B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...